How were Syneron Medical's earnings last quarter?

Syneron Medical Ltd (NASDAQ:ELOS) issued its earnings results on Thursday, August, 4th. The medical equipment provider reported $0.09 EPS for the quarter, beating analysts' consensus estimates of $0.06 by $0.03. The medical equipment provider earned $75 million during the quarter, compared to analyst estimates of $75.72 million. The business's revenue was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.07 earnings per share.

What other stocks do shareholders of Syneron Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneron Medical investors own include Micron Technology (MU) , Advanced Micro Devices (AMD) , BIOLASE (BIOL) , Cisco Systems (CSCO) , Freeport-McMoRan (FCX) , Gilead Sciences (GILD) , Lannett (LCI) , Rite Aid (RAD) , Ambarella (AMBA) and Citigroup (C) .

NASDAQ:ELOS

Syneron Medical (ELOS) Stock Price, News & Analysis

→ Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad)

Free ELOS Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $11.00
▼
$11.00
50-Day Range: N/A
52-Week Range: $6.18
▼
$11.43

Volume: N/A
Average Volume: 562,777 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Syneron Medical alerts:

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

About Syneron Medical Stock (NASDAQ:ELOS)

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

ELOS Stock News Headlines

March 13, 2024 | uk.investing.com

Apax Global Alpha Ltd (APAX)

November 14, 2023 | morningstar.com

Elos Medtech AB Class B ELOS B

April 17, 2024 | Banyan Hill Publishing (Ad)

Don’t Miss Out on the AI Gold Rush That’s Just Getting Started

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

August 21, 2023 | thestreet.com

Syneron Medical Stock Hits New 52-Week Low (ELOS)

July 13, 2023 | wsj.com

Elos Medtech AB Series B

June 15, 2023 | thestreet.com

Syneron Hires Finance Chief

May 11, 2023 | marketwatch.com

Radio Frequency Beauty Instrument Market 2023 Size, Share and Trends Analysis – Syneron Medical, Lumenis, Valeant Pharmaceutical International

January 21, 2023 | cnbc.com

As of July 1, your medical debt may no longer hurt your credit score—here's why

April 17, 2024 | Banyan Hill Publishing (Ad)

Don’t Miss Out on the AI Gold Rush That’s Just Getting Started

January 18, 2022 | thestreet.com

Syneron Medical Stock Hits New 52-Week High (ELOS)

January 7, 2022 | thestreet.com

Syneron Medical (ELOS) Stock Spikes Today on Strong Fourth Quarter Guidance

See More Headlines

Receive ELOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syneron Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/04/2016
Today: 4/17/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:ELOS
CUSIP: N/A
CIK: 1291361
Web: syneron-candela.com
Phone: +972-7-32442200
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Shimon Eckhouse Ph.D.
Chairman of the Board
Amit Meridor
Chief Executive Officer
Bio & Compensation -
Hugo Goldman
Chief Financial Officer
Bio & Compensation -
Erik Dowell
Vice President-North America
William Griffing
Chief Executive Officer - Syneron Candela North America
Shlomo Alkalay
Chief Operating Officer
Lisa A. Soderquist
Chief Human Resource Officer
Bio & Compensation -
Robert Ruck
Executive Vice President, Asia Pacific
Robert Fielitz
Vice President and Managing Director of Europe, Middle East and Africa
Sarit Soccary Ben-Yochanan
Vice President - Business Development & Strategy

ELOS Stock Analysis - Frequently Asked Questions

How were Syneron Medical's earnings last quarter?: Syneron Medical Ltd (NASDAQ:ELOS) issued its earnings results on Thursday, August, 4th. The medical equipment provider reported $0.09 EPS for the quarter, beating analysts' consensus estimates of $0.06 by $0.03. The medical equipment provider earned $75 million during the quarter, compared to analyst estimates of $75.72 million. The business's revenue was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.07 earnings per share.
What other stocks do shareholders of Syneron Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Syneron Medical investors own include Micron Technology (MU), Advanced Micro Devices (AMD), BIOLASE (BIOL), Cisco Systems (CSCO), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Lannett (LCI), Rite Aid (RAD), Ambarella (AMBA) and Citigroup (C).

This page (NASDAQ:ELOS) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Syneron Medical (ELOS) Stock Price, News & Analysis

About Syneron Medical Stock (NASDAQ:ELOS)

ELOS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

ELOS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info